Quick Answer
Sunshine Biopharma Inc. reported Shares Outstanding of 2.58 million shares for fiscal year 2024.
Sunshine Biopharma Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2024 | 2.58M | +18313.5% |
| 2023 | 14,012 | -99.9% |
| 2022 | 22.59M | +771.6% |
| 2021 | 2.59M | +49.6% |
| 2020 | 1.73M | -95.1% |
| 2019 | 35.32M | +724.7% |
| 2018 | 4.28M | -90.7% |
| 2017 | 45.94M | -94.0% |
| 2016 | 769.40M | +288.1% |
| 2015 | 198.27M | +169.6% |
| 2014 | 73.55M | +22.0% |
| 2013 | 60.30M | +17.3% |
| 2012 | 51.42M | +5.5% |
| 2011 | 48.73M | +58.8% |
| 2010 | 30.69M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 4.56M | +127.8% | +0.0% |
| June 30, 2025 | 4.56M | +289.2% | +68.3% |
| March 31, 2025 | 2.71M | +172.2% | +4.9% |
| December 31, 2024 | 2.58M | +18313.5% | +29.0% |
| September 30, 2024 | 2.00M | -92.2% | +70.8% |
| June 30, 2024 | 1.17M | -95.5% | +17.7% |
| March 31, 2024 | 994,529 | -95.5% | +6997.7% |
| December 31, 2023 | 14,012 | -99.9% | -99.9% |
- Sunshine Biopharma Inc. showed an increase of +18313.5% in Shares Outstanding compared to the prior fiscal year.
- Over the 2010–2024 period, Sunshine Biopharma Inc.’s shares outstanding has declined by 91.6% (from 30.69 million shares to 2.58 million shares).
- The most recent figure is from Sunshine Biopharma Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on April 1, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: